Sale!

KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the KRAS gene associated with Noonan Syndrome Type 3. This advanced next-generation sequencing test provides crucial diagnostic information for individuals presenting with characteristic facial features, cardiac abnormalities, developmental delays, and other symptoms of this rare genetic disorder. The test offers definitive genetic confirmation, enabling personalized medical management and family planning decisions. Available for $500 USD, this specialized genetic testing provides valuable insights for patients and healthcare providers managing Noonan Syndrome Type 3 cases.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test

Comprehensive Genetic Testing for Noonan Syndrome Type 3

The KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals suspected of having Noonan Syndrome Type 3. This specialized test utilizes cutting-edge Next-Generation Sequencing (NGS) technology to analyze the KRAS gene, which plays a critical role in the RAS/MAPK signaling pathway. Mutations in this gene are specifically associated with Noonan Syndrome Type 3, a rare genetic disorder characterized by distinctive facial features, cardiac abnormalities, and developmental challenges.

What This Test Measures and Detects

Our advanced NGS genetic testing platform provides comprehensive analysis of the KRAS gene to identify:

  • Pathogenic mutations in the KRAS gene associated with Noonan Syndrome Type 3
  • Specific genetic variants affecting the RAS/MAPK signaling pathway
  • Both inherited and de novo (spontaneous) mutations
  • Various mutation types including missense, nonsense, and frameshift variants
  • Genetic markers that influence disease severity and progression

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with symptoms suggestive of Noonan Syndrome Type 3, including:

  • Characteristic facial features: hypertelorism, down-slanting palpebral fissures, low-set ears
  • Cardiac abnormalities such as pulmonary valve stenosis or hypertrophic cardiomyopathy
  • Developmental delays and learning disabilities
  • Short stature and growth hormone deficiency
  • Feeding difficulties in infancy
  • Chest deformities including pectus excavatum or carinatum
  • Cryptorchidism in males
  • Bleeding tendencies and coagulation abnormalities

Clinical Benefits of KRAS Gene Testing

Undergoing the KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test provides numerous clinical advantages:

  • Definitive Diagnosis: Obtain conclusive genetic confirmation of Noonan Syndrome Type 3
  • Personalized Treatment: Enable targeted medical management based on specific genetic findings
  • Family Planning: Provide accurate genetic counseling for family members and future pregnancies
  • Early Intervention: Facilitate timely implementation of appropriate therapies and monitoring
  • Prognostic Information: Understand potential disease progression and associated health risks
  • Research Contribution: Contribute to ongoing medical research and understanding of rare genetic disorders

Understanding Your Test Results

Our comprehensive genetic testing provides detailed results with expert interpretation:

  • Positive Result: Indicates the presence of a pathogenic KRAS gene mutation associated with Noonan Syndrome Type 3. This confirms the diagnosis and enables targeted medical management.
  • Negative Result: Suggests that no pathogenic KRAS mutations were detected, though clinical correlation with symptoms remains important.
  • Variant of Uncertain Significance (VUS): Identifies genetic changes whose clinical significance is currently unknown, requiring ongoing monitoring and potential family studies.

All results are accompanied by detailed genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Pricing Information

Test Name Discount Price Regular Price
KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test 500 USD 700 USD

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality testing regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic conditions affect your health decisions. Our KRAS Gene Noonan Syndrome Type 3 NGS Genetic DNA Test provides the definitive answers you need for proper diagnosis and management. With our discounted price of $500 USD and comprehensive genetic counseling support, you can make informed decisions about your health and future.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Our expert staff is ready to guide you through the testing process and help you understand your genetic health.